Systemic Avastin Therapy in Age-Related Macular Degeneration
NCT00531024
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Macular Degeneration
Interventions
DRUG:
Bevacizumab
DRUG:
Sodium Chloride
Sponsor
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery